BRIAN HORNUNG: Open Payments
NPI 1558364117 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 35 payments from 14 companies in 2025. Trend: 2023 $192 · 2024 $782 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $140 |
| Novo Nordisk Inc | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Abbott Laboratories | 3 | $60 |
| Astellas Pharma US Inc | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $30 |
| Radius Health, Inc. | 1 | $24 |
Products named: ELIQUIS, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Veozah, Ozempic, AIRSUPRA, MOUNJARO, OTEZLA.
Industry payments across KS — which companies pay providers there.
